ask="4.230"
ask_size="200"
average_daily_volume="574608"
bid="2.530"
bid_size="2000"
book_value="2.303"
change="-0.055"
change_from_200_day_moving_average="-0.463"
change_from_50_day_moving_average="-0.213"
change_from_52_week_high="-2.575"
change_From_52_week_low="1.125"
change_in_percent="-1.285%"
close="4.225"
dividend_pay_date="12/30/2013"
dividend_per_share="0.000"
dividend_yield="0.000"
earnings_per_share="-1.677"
ebitda="-43.09M"
eps_estimate_current_year="-1.470"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="-0.840"
ex_dividend_date="12/31/2013"
float_shares="40197000"
high="4.320"
high_52_weeks="6.800"
last_trade_date="2/3/2017"
last_trade_price="4.225"
last_trade_size="2493"
last_trade_time="4:00pm"
low="4.200"
low_52_weeks="3.100"
market_capitalization="276.43M"
moving_average_200_day="4.688"
moving_average_50_day="4.438"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="9.830"
open="4.280"
pe_ratio="N/A"
peg_ratio="-0.100"
percent_change_from_200_day_moving_average="-9.868%"
percent_change_from_50_day_moving_average="-4.790%"
percent_change_from_52_week_high="-37.868%"
percent_change_from_52_week_low="+36.290%"
previous_close="4.280"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.858"
price_per_sales="6.961"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="6.300"
stock_exchange="NMS"
symbol="ARLZ"
volume="367114"
weeks_range_52="3.100 - 6.800"
